Biocure Technology Inc. (CSE:CURE.X)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
At close: Aug 13, 2026
Biocure Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.11M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 2.56M |
| RAMM Pharma | 1.89M |
| Syntheia | 852.19K |
| Bee Vectoring Technologies International | 115.21K |
| EnviroMetal Technologies | -660.00 |
| Cloud3 Ventures | -64.41K |
| SOL Global Investments | -17.97M |
Biocure Technology News
- 5 weeks ago - Biocure Technology Inc. enters into Definitive Share Exchange Agreement to acquire Glorious Success Limited - TheNewswire
- 4 months ago - Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting - TheNewswire
- 1 year ago - CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X) - Newsfile Corp
- 3 years ago - Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology - GlobeNewsWire
- 3 years ago - Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction - Newsfile Corp
- 4 years ago - Biocure Corporate Update - Newsfile Corp
- 4 years ago - Biocure Corporate Update and Financing - Newsfile Corp
- 5 years ago - Biocure Technology Inc. Announces Focus on its own CAR T-cell Therapy Targeting Chronic Lymphocytic Leukemia ("CLL") and Solid Tumor Cancers and Intent to Apply for Patents - Newsfile Corp